Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBTC Capital Management, Inc.
Latest Disclosed Ownership16,540 shares
Latest Disclosed Value $ 2,526,502
BTC Capital Management, Inc. reports 4.82% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 20, 2026 - BTC Capital Management, Inc. filed a 13F-HR form disclosing ownership of 16,540 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $2,526,485 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 17,378 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -4.82% during the quarter. The current value of the position is $2,467,106 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 16,540 -838 -4.82 2,527 5.38 0.0896
2026-01-15 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 17,378 99 0.57 2,397 8.22 0.1672
2025-11-06 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 17,279 1,528 9.70 2,216 16.21 0.1529
2025-07-11 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 15,751 368 2.39 1,906 11.20 0.1556
2025-04-08 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 15,383 473 3.17 1,715 18.45 0.1568
2025-01-23 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 14,910 1,608 12.09 1,447 -5.36 0.1341
2024-10-21 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 13,302 821 6.58 1,530 15.14 0.1360
2024-07-19 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 12,481 -420 -3.26 1,329 6.50 0.1234
2024-04-11 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 12,901 1,326 11.46 1,248 5.77 0.1141
2023-10-17 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 11,575 462 4.16 1,179 5.74 0.1361
2023-07-11 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 11,113 -143 -1.27 1,115 9.42 0.1206
2023-04-07 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 11,256 -934 -7.66 1,020 -7.78 0.1173
2023-01-27 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 12,190 624 5.40 1,106 25.71 0.1330
2022-10-17 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 11,566 893 8.37 879 -2.44 0.1149
2022-08-08 2022-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 10,673 3,681 52.65 901 45.79 0.1101
2022-07-25 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 21,346 14,354 1,802 0.2186
2022-05-06 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,992 -3,691 -34.55 618 -34.12 0.0440
2022-05-06 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 20,748 1,828
2022-02-09 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 10,683 568 5.62 938 13.42 0.0927
2021-11-15 2021-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 10,115 205 2.07 827 -8.72 0.0928
2021-08-02 2021-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 9,910 -1,832 -15.60 906 -9.67 0.1032
2021-05-04 2021-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 11,742 678 6.13 1,003 -4.11 0.1120
2021-01-28 2020-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 11,064 1,197 12.13 1,046 21.63 0.1248
2020-10-14 2020-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 9,867 3,566 56.59 860 56.36 0.1200
2020-08-04 2020-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,301 6,301 550 0.0841
2020-05-06 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -4,612 -100.00 0 -100.00
2020-02-13 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,612 1,682 57.41 434 70.20 0.0618
2019-10-18 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,930 -2,190 -42.77 255 -45.63 0.0407
2019-07-26 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 5,120 2,215 76.25 469 68.10 0.0759
2019-05-16 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,905 -134 -4.41 279 7.72 0.0445
2019-02-13 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,039 375 14.08 259 13.10 0.0464
2018-11-14 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,664 -409 -13.31 229 -2.55 0.0391
2018-08-15 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,073 -2,293 -42.73 235 -45.73 0.0556
2018-05-09 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 5,366 183 3.53 433 -0.23 0.0709
2018-01-29 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 5,183 2,735 111.72 434 108.65 0.0747
2017-11-06 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,448 -225 -8.42 208 -6.73 0.0372
2017-08-02 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,673 2,673 223 0.0403
2016-10-26 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -6,773 -100.00 0 -100.00
2016-08-01 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,773 3,158 87.36 560 114.56 0.1212
2016-05-02 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,615 222 6.54 261 -10.62 0.0602
2016-02-08 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,393 -1,746 -33.98 292 -38.53 0.0684
2015-10-22 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 5,139 5,139 475 0.1144
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.